FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125922759> ?p ?o ?g. }

• W2125922759 endingPage "297" @default.
• W2125922759 startingPage "289" @default.
• W2125922759 abstract "Previous preclinical studies have shown that regional temozolomide therapy via isolated limb infusion is more effective than melphalan, the current drug of choice for regional chemotherapy for advanced extremity melanoma. The aim of this study was to determine whether hyperthermia could further augment the efficacy of temozolomide, an alkylating agent, against melanoma and improve its therapeutic index in a rat model of isolated limb infusion.Athymic rats bearing s.c. human melanoma xenografts (DM6) in their hind limbs were randomized to a 15-minute isolated limb infusion procedure with or without temozolomide at room temperature, normothermic (37.5 degrees C), or hyperthermic (43 degrees C) conditions.The concomitant administration of hyperthermia during an infusion with temozolomide led to the greatest increase in tumor growth delay, decreased proliferative index, and increased cell death. Isolated limb infusion treatment with a low dose (350 mg/kg) of temozolomide was ineffective at producing tumor growth delay (P = 0.07). Similarly, temozolomide infusion under normothermia yielded minimal tumor growth delay (P = 0.08). In contrast, the combination of hyperthermia plus temozolomide treatment produced marked tumor growth delay of 10.4 days (P = 0.02) with minimal toxicity. The addition of heat to temozolomide treatment yielded the smallest proliferative index (P = 0.001), while markedly increasing the level of apoptosis 48 hours after isolated limb infusion.This study, the first to examine the interaction between hyperthermia and temozolomide, shows a strong, synergistic antitumor effect when hyperthermia is combined with temozolomide for regional treatment of melanoma confined to an extremity. The mechanism of this synergy seems to be through an augmentation, by hyperthermia, of the antiproliferative and proapoptotic effects of temozolomide." @default.
• W2125922759 created "2016-06-24" @default.
• W2125922759 creator A5008586187 @default.
• W2125922759 creator A5015827608 @default.
• W2125922759 creator A5016994371 @default.
• W2125922759 creator A5031189107 @default.
• W2125922759 creator A5034430886 @default.
• W2125922759 creator A5043051278 @default.
• W2125922759 creator A5057302927 @default.
• W2125922759 creator A5057371623 @default.
• W2125922759 creator A5068565845 @default.
• W2125922759 creator A5071519548 @default.
• W2125922759 creator A5083512608 @default.
• W2125922759 date "2006-01-01" @default.
• W2125922759 modified "2023-10-15" @default.
• W2125922759 title "Optimizing a Novel Regional Chemotherapeutic Agent against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity" @default.
• W2125922759 cites W1889451488 @default.
• W2125922759 cites W1917632054 @default.
• W2125922759 cites W1964131973 @default.
• W2125922759 cites W1974944573 @default.
• W2125922759 cites W1975045673 @default.
• W2125922759 cites W1979006071 @default.
• W2125922759 cites W1979581432 @default.
• W2125922759 cites W1981737891 @default.
• W2125922759 cites W2002370461 @default.
• W2125922759 cites W2007984865 @default.
• W2125922759 cites W2018435418 @default.
• W2125922759 cites W2023806727 @default.
• W2125922759 cites W2039403483 @default.
• W2125922759 cites W2041852769 @default.
• W2125922759 cites W2042620152 @default.
• W2125922759 cites W2050274950 @default.
• W2125922759 cites W2050499573 @default.
• W2125922759 cites W2053924995 @default.
• W2125922759 cites W2059239046 @default.
• W2125922759 cites W2065807715 @default.
• W2125922759 cites W2068399616 @default.
• W2125922759 cites W2079135822 @default.
• W2125922759 cites W2085064173 @default.
• W2125922759 cites W2090926682 @default.
• W2125922759 cites W2092163409 @default.
• W2125922759 cites W2104631267 @default.
• W2125922759 cites W2106537730 @default.
• W2125922759 cites W2112639091 @default.
• W2125922759 cites W2114766837 @default.
• W2125922759 cites W2125578049 @default.
• W2125922759 cites W2131887263 @default.
• W2125922759 cites W2136267489 @default.
• W2125922759 cites W2138302361 @default.
• W2125922759 cites W2139391544 @default.
• W2125922759 cites W2140598289 @default.
• W2125922759 cites W2166554098 @default.
• W2125922759 cites W2331911495 @default.
• W2125922759 doi "https://doi.org/10.1158/1078-0432.ccr-05-0210" @default.
• W2125922759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16397054" @default.
• W2125922759 hasPublicationYear "2006" @default.
• W2125922759 type Work @default.
• W2125922759 sameAs 2125922759 @default.
• W2125922759 citedByCount "42" @default.
• W2125922759 countsByYear W21259227592012 @default.
• W2125922759 countsByYear W21259227592013 @default.
• W2125922759 countsByYear W21259227592014 @default.
• W2125922759 countsByYear W21259227592015 @default.
• W2125922759 countsByYear W21259227592016 @default.
• W2125922759 countsByYear W21259227592017 @default.
• W2125922759 countsByYear W21259227592018 @default.
• W2125922759 countsByYear W21259227592020 @default.
• W2125922759 countsByYear W21259227592022 @default.
• W2125922759 countsByYear W21259227592023 @default.
• W2125922759 crossrefType "journal-article" @default.
• W2125922759 hasAuthorship W2125922759A5008586187 @default.
• W2125922759 hasAuthorship W2125922759A5015827608 @default.
• W2125922759 hasAuthorship W2125922759A5016994371 @default.
• W2125922759 hasAuthorship W2125922759A5031189107 @default.
• W2125922759 hasAuthorship W2125922759A5034430886 @default.
• W2125922759 hasAuthorship W2125922759A5043051278 @default.
• W2125922759 hasAuthorship W2125922759A5057302927 @default.
• W2125922759 hasAuthorship W2125922759A5057371623 @default.
• W2125922759 hasAuthorship W2125922759A5068565845 @default.
• W2125922759 hasAuthorship W2125922759A5071519548 @default.
• W2125922759 hasAuthorship W2125922759A5083512608 @default.
• W2125922759 hasBestOaLocation W21259227591 @default.
• W2125922759 hasConcept C126322002 @default.
• W2125922759 hasConcept C2776694085 @default.
• W2125922759 hasConcept C2777389519 @default.
• W2125922759 hasConcept C2777658100 @default.
• W2125922759 hasConcept C2778684742 @default.
• W2125922759 hasConcept C2779384505 @default.
• W2125922759 hasConcept C2779949491 @default.
• W2125922759 hasConcept C2780964509 @default.
• W2125922759 hasConcept C29730261 @default.
• W2125922759 hasConcept C502942594 @default.
• W2125922759 hasConcept C71924100 @default.
• W2125922759 hasConcept C98274493 @default.
• W2125922759 hasConceptScore W2125922759C126322002 @default.
• W2125922759 hasConceptScore W2125922759C2776694085 @default.
• W2125922759 hasConceptScore W2125922759C2777389519 @default.
• W2125922759 hasConceptScore W2125922759C2777658100 @default.

• next